Skin & Soft Tissue Diseases

>

Latest News

Treating Persistent Methicillin-susceptible Staphylococcus aureus (MSSA) Bacteremia
Treating Persistent Methicillin-susceptible Staphylococcus aureus (MSSA) Bacteremia

January 12th 2024

Emerging treatment options for patients with persistently positive blood cultures with Methicillin-Susceptible Staphylococcus aureus (MSSA).

Two Pragmatic Approaches to Skin and Soft Tissue Infections
Two Pragmatic Approaches to Skin and Soft Tissue Infections

November 14th 2023

Should Linezolid Replace Clindamycin for Necrotizing Soft Tissue Infections?
Should Linezolid Replace Clindamycin for Necrotizing Soft Tissue Infections?

October 27th 2023

FDA Approves VP-102 for Skin Virus That Affects Mostly Children
FDA Approves VP-102 for Skin Virus That Affects Mostly Children

July 22nd 2023

New York City Declares Mpox Outbreak Is Over
New York City Declares Mpox Outbreak Is Over

February 2nd 2023

Latest CME Events & Activities

State-of-the-Art CMV Care: Experts’ Perspectives on Primary/Secondary Prevention and Management of Refractory/Resistant Infections

View More

Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?

View More

Understanding RSV: What You Need to Know to Prevent and Treat Respiratory Syncytial Virus in Your Patients

View More

Respiratory Syncytial Virus: Understanding the Infection Burden and Anticipating the Impact of Vaccines

View More

(CME Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME

View More

(COPE Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME

View More

Medical Crossfire®: Which Patients with Hematologic Malignancies are at Risk for Secondary Immunodeficiency (SID)… and How Can We Leverage Evidence to Improve Their Outcomes?

View More

Addressing Healthcare Inequities™ in Glaucoma Management – Understanding Challenges in Segmented Patient Populations (CME Track)

View More

Community Practice Connections™: Real-World Applications of Novel Therapies Across TNBC and Addressing Disparities in Care

View More

Advances in TNBC: Communicating with Your Patients About Clinical Trial Awareness and Treatment Concerns to Improve Clinical Outcomes

View More

Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations

View More

Community Oncology Connections™: Overcoming Barriers to Testing, Trial Access, and Equitable Care in Cancer

View More

Addressing Healthcare Inequities: Bridging the Gap in Multiple Sclerosis – A Focus on Clinical and Healthcare Disparities in Black Patients

View More

Overcoming Racial Disparities in Multiple Myeloma Outcomes and Clinical Trials: How We are Moving Care Forward Today

View More

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

More News

© 2024 MJH Life Sciences

All rights reserved.